SELP and malignant colon neoplasm: Blocking CD62P resulted in a decrease of metastatic colon cancer foci in the lungs of mice and a diminished binding of platelets to tumor cells, indicating that CD62P is directly involved in the protumoral properties of platelets [68,69,70].